+

LIVING WITH
A PFO AFTER A STROKE

During a stroke, brain cells do not get the oxygen they need. This causes brain cells to die. The effects of a stroke depend on where in the brain it occurs and how much cell death it causes.

There are many physical, cognitive and emotional changes that are common after a stroke:

  • Trouble speaking or understanding language
  • Feelings of anger or depression
  • Forgetfulness, confusion
  • Weakness, paralysis, fatigue

HOW TO REDUCE RISK OF ANOTHER STROKE

Once you have had a stroke, you are likely to have another one.¹ You have the power to reduce that risk. The American Stroke Association suggests eating healthy meals, taking your medicines as prescribed, and being as physically active as you are able.² Keep in mind that lifestyle changes will not close your PFO.

Learn how PFO closure reduces risk

Advice from the american stroke association

BLOOD PRESSURE
High blood pressure is a significant risk factor for stroke. Work with your health care provider to bring your blood pressure to goal.

CHOLESTEROL
Have your cholesterol checked regularly. Medication and healthy lifestyle habits can help lower your cholesterol levels.

BLOOD SUGAR
Have your blood sugar tested. Some people have diabetes, and don’t know it until something, like a stroke, happens.

SMOKING
Cigarette smoking increases the risk of stroke. If you smoke, talk with your health care provider about how to quit.

PHYSICAL ACTIVITY
Physical activity reduces the risk of high blood pressure, high cholesterol, diabetes, and maybe a stroke itself. It can also improve recovery. Your health care team can help with a plan that’s right for you.

ALCOHOL
If you drink alcohol, limit it to 1 drink a day for women or 2 drinks a day for men.

Reduce your risk of another stroke

You can take charge of reducing your risk. Talk to your doctor about lifestyle changes, medicine, and PFO closure.

FIND A PHYSICIAN/CENTER

MAT-2002546 v7.0 | Item approved for U.S. use only.

References
  1. Benjamin EJ, Muntner P, Alonso A, et al. Heart disease and stroke statistics—2019 update: a report from the American Heart Association. Circulation. 2019;139:e56–e528. doi: 10.1161/CIR.0000000000000659
  2. "Preventing Another Stroke." American Stroke Association. American Heart Association, 2021, www.stroke.org/en/life-after-stroke/preventing-another-stroke.
Important Safety Information

Rx Only

AMPLATZER™ TALISMAN™ PFO OCCLUDER

INDICATION FOR USE


The Amplatzer™ Talisman™ PFO Occluder is indicated for percutaneous transcatheter closure of a patent foramen ovale (PFO) to reduce the risk of recurrent ischemic stroke in patients, predominantly between the ages of 18 and 60 years, who have had a stroke due to a presumed paradoxical embolism, as determined by a neurologist and cardiologist following an evaluation to exclude other causes of ischemic stroke.

CONTRAINDICATIONS

Presence of thrombus at the intended site of implant, or documented evidence of venous thrombus in the vessels through which access to the defect is gained; Patients with intra-cardiac thrombus, mass, vegetation, or tumor; Patients whose vasculature, through which access to the PFO is gained, is inadequate to accommodate the appropriate sheath size; Patients with anatomy in which the required Amplatzer™ Talisman™ PFO device size would interfere with other intracardiac or intravascular structures, such as valves or pulmonary veins; Patients with another source of right-to-left shunts, including an atrial septal defect and/or fenestrated septum; Patients with active endocarditis or other untreated infections; Patients who are unable to tolerate intra-procedural anticoagulation or post-procedural anti-platelet therapy.

POTENTIAL ADVERSE EVENTS

Potential adverse events that may occur during or after a procedure using this device may include, but are not limited to: Air embolus; Allergic reaction/toxic effect due to: anesthesia, contrast media, medication, or metal; Arrhythmia; Arteriovenous fistulae; Bleeding; Cardiac perforation; Cardiac tamponade; Chest pain; Death; Deep vein thrombosis; Device embolization; Device erosion; Endocarditis; Esophagus injury; Fever; Headache/migraine; Hematoma; Hypertension/hypotension; Infection; Myocardial infarction; Pacemaker placement secondary to PFO device closure; Pain; Pericardial effusion; Pericarditis; Peripheral embolism; Pseudoaneurysm; Pulmonary embolism; Reintervention for residual shunt/device removal; Stroke; Transient ischemic attack; Thrombus formation; Valvular regurgitation; Vascular access site injury; Vessel perforation.

Copyright © 2025 Abbott, 3200 Lakeside Dr, Santa Clara, 95054, U.S.A.
CAUTION: Product(s) intended for use by or under the direction of a physician. Prior to use, reference to the Instructions for Use, inside the product carton (when available) or at www.eifu.abbott for more detailed information on Indications, Contraindications, Warnings, Precautions and Adverse Events.
Illustrations are artist’s representations only and should not be considered as engineering drawings or photographs. Photos on file at Abbott.
Unless otherwise specified, all product names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates.
No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.
MAT-2003161 v10.0 | Item approved for U.S. use only.

YOU ARE ABOUT TO LEAVE
www.pfostroke.com

You are now leaving www.pfostroke.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

OkCancel
+